{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:00:09Z","timestamp":1780621209246,"version":"3.54.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Major Program of Medical Science and Technology Project of Health Commission of Henan Province","award":["SBGJ202101011"],"award-info":[{"award-number":["SBGJ202101011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00810-7","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T10:04:07Z","timestamp":1776852247000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell analysis highlights the role of CD4+ IFN-I-related T cells in Behcet\u2019s uveitis during Interferon\u03b1-2a therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Meiqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2647-6619","authenticated-orcid":false,"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"issue":"1","key":"810_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","volume":"27","author":"CM Deuter","year":"2008","unstructured":"Deuter CM, et al. Beh\u00e7et\u2019s disease: ocular effects and treatment. Prog Retin Eye Res. 2008;27(1):111\u201336.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"810_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ophtha.2007.04.056","volume":"115","author":"P Yang","year":"2008","unstructured":"Yang P, et al. Clinical features of chinese patients with Beh\u00e7et\u2019s disease. Ophthalmology. 2008;115(2):312\u2013e3184.","journal-title":"Ophthalmology"},{"issue":"2","key":"810_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0039-6257(97)00026-X","volume":"42","author":"RK George","year":"1997","unstructured":"George RK, et al. Ocular immunopathology of Beh\u00e7et\u2019s disease. Surv Ophthalmol. 1997;42(2):157\u201362.","journal-title":"Surv Ophthalmol"},{"key":"810_CR4","unstructured":"Lu A, et al. Global research status regarding uveitis in the last decade. Ocul Immunol Inflamm. 2023:1\u201310."},{"key":"810_CR5","doi-asserted-by":"publisher","first-page":"765377","DOI":"10.3389\/fimmu.2021.765377","volume":"12","author":"P Yang","year":"2021","unstructured":"Yang P, Ohno S, Zierhut M. Editorial: New Insights Into Uveitis: Immunity, Genes, and Microbes. Front Immunol. 2021;12:765377.","journal-title":"Front Immunol"},{"issue":"2","key":"810_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, et al. Genome-wide association analysis identifies new susceptibility loci for Beh\u00e7et\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202\u20137.","journal-title":"Nat Genet"},{"key":"810_CR7","first-page":"880","volume":"16","author":"W Chi","year":"2010","unstructured":"Chi W, et al. Production of interleukin-17 in Behcet\u2019s disease is inhibited by cyclosporin A. Mol Vis. 2010;16:880\u20136.","journal-title":"Mol Vis"},{"issue":"3","key":"810_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ophtha.2014.09.025","volume":"122","author":"S Hou","year":"2015","unstructured":"Hou S, et al. Genetic variations of IL17F and IL23A show associations with Beh\u00e7et\u2019s disease and Vogt-Koyanagi-Harada syndrome. Ophthalmology. 2015;122(3):518\u201323.","journal-title":"Ophthalmology"},{"issue":"7","key":"810_CR9","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","volume":"49","author":"W Chi","year":"2008","unstructured":"Chi W, et al. Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis. Investig Ophthalmol Vis Sci. 2008;49(7):3058\u201364.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"810_CR10","first-page":"291","volume":"8","author":"A Hedayatfar","year":"2013","unstructured":"Hedayatfar A. Beh\u00e7et\u2019s Disease: Autoimmune or Autoinflammatory? J ophthalmic Vis Res. 2013;8:291\u20133.","journal-title":"J ophthalmic Vis Res"},{"issue":"1","key":"810_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/rheumatology\/keab253","volume":"61","author":"A Filleron","year":"2021","unstructured":"Filleron A, et al. Regulatory T cell\/Th17 balance in the pathogenesis of paediatric Beh\u00e7et disease. Rheumatology (Oxford). 2021;61(1):422\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.preteyeres.2020.100866","volume":"80","author":"Z Zhong","year":"2021","unstructured":"Zhong Z, et al. Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Prog Retin Eye Res. 2021;80:100866.","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"810_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/09273948.2017.1384026","volume":"27","author":"P Yang","year":"2019","unstructured":"Yang P, et al. Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Beh\u00e7et\u2019s Uveitis Not Responding to Conventional Therapy. Ocul Immunol Inflamm. 2019;27(1):7\u201314.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"810_CR14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/09273948.2020.1815797","volume":"30","author":"L De Simone","year":"2022","unstructured":"De Simone L, et al. Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Beh\u00e7et\u2019s Uveitis: Customizing Therapy according to the Clinical Features. Ocul Immunol Inflamm. 2022;30(2):506\u201314.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"810_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1089\/jop.2018.0083","volume":"35","author":"H Celiker","year":"2019","unstructured":"Celiker H, Kazokoglu H, Direskeneli H. Factors Affecting Relapse and Remission in Beh\u00e7et\u2019s Uveitis Treated with Interferon Alpha2a. J Ocul Pharmacol Ther. 2019;35(1):58\u201365.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"810_CR16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","volume":"6","author":"EC Borden","year":"2007","unstructured":"Borden EC, et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov. 2007;6(12):975\u201390.","journal-title":"Nat Rev Drug Discov"},{"key":"810_CR17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","volume":"23","author":"AN Theofilopoulos","year":"2005","unstructured":"Theofilopoulos AN, et al. Type I interferons (alpha\/beta) in immunity and autoimmunity. Annu Rev Immunol. 2005;23:307\u201336.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"810_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.femsim.2004.09.005","volume":"43","author":"DJ Ordway","year":"2005","unstructured":"Ordway DJ, et al. Gamma delta T cell responses associated with the development of tuberculosis in health care workers. FEMS Immunol Med Microbiol. 2005;43(3):339\u201350.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"810_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1093\/rheumatology\/keh311","volume":"43","author":"M Treusch","year":"2004","unstructured":"Treusch M, et al. Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet\u2019s disease. Rheumatology (Oxford). 2004;43(10):1275\u201382.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"810_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.autrev.2014.12.009","volume":"14","author":"M Touzot","year":"2015","unstructured":"Touzot M, et al. IFN-\u03b1 induces IL-10 production and tilt the balance between Th1 and Th17 in Beh\u00e7et disease. Autoimmun rev. 2015;14(5):370\u20135.","journal-title":"Autoimmun rev"},{"issue":"8","key":"810_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50(8):1\u201314.","journal-title":"Exp Mol Med"},{"issue":"2","key":"810_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.it.2020.12.004","volume":"42","author":"C Liu","year":"2021","unstructured":"Liu C, et al. Cell Development: Old Tales Retold By Single-Cell RNA Sequencing. Trends Immunol. 2021;42(2):165\u201375.","journal-title":"Trends Immunol"},{"issue":"8697","key":"810_CR23","first-page":"1078","volume":"335","author":"ISGF Disease","year":"1990","unstructured":"Disease. ISGF. Criteria for diagnosis of Beh\u00e7et\u2019s disease. Lancet (London England). 1990;335(8697):1078\u201380.","journal-title":"Lancet (London England)"},{"key":"810_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajo.2021.03.061","volume":"228","author":"SOUN Group","year":"2021","unstructured":"Group SOUN. Development of Classification Criteria for the Uveitides. Am J Ophthalmol. 2021;228:96\u2013105.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"810_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"B A","year":"2018","unstructured":"A B, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"6","key":"810_CR26","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.crmeth.2023.100498","volume":"3","author":"S Morabito","year":"2023","unstructured":"Morabito S, et al. hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep methods. 2023;3(6):100498.","journal-title":"Cell Rep methods"},{"issue":"3","key":"810_CR27","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Cambridge (Mass)). 2021;2(3):100141.","journal-title":"Innov (Cambridge (Mass))"},{"issue":"1","key":"810_CR28","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"4","key":"810_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"810_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics. 2018;19(1):477.","journal-title":"BMC Genomics"},{"issue":"12","key":"810_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"810_CR32","doi-asserted-by":"publisher","first-page":"D354","DOI":"10.1093\/nar\/gkj102","volume":"34","author":"M Kanehisa","year":"2006","unstructured":"Kanehisa M, et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34:D354\u20137.","journal-title":"Nucleic Acids Res"},{"key":"810_CR33","doi-asserted-by":"publisher","first-page":"687975","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng D, et al. Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. Front Immunol. 2021;12:687975.","journal-title":"Front Immunol"},{"issue":"5","key":"810_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"key":"810_CR35","doi-asserted-by":"crossref","unstructured":"Racle J, et al. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. eLife. 2017;6.","DOI":"10.7554\/eLife.26476"},{"issue":"1","key":"810_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13059-017-1256-5","volume":"18","author":"B Li","year":"2017","unstructured":"Li B, Liu JS, Liu XS. Revisit linear regression-based deconvolution methods for tumor gene expression data. Genome Biol. 2017;18(1):127.","journal-title":"Genome Biol"},{"issue":"7269","key":"810_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312.","journal-title":"Nature"},{"key":"810_CR38","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ. UCell: Robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138.","journal-title":"Comput Struct Biotechnol J"},{"key":"810_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"43","key":"810_CR40","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"810_CR41","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"810_CR42","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"26","key":"810_CR43","doi-asserted-by":"publisher","first-page":"e2204289119","DOI":"10.1073\/pnas.2204289119","volume":"119","author":"W Zheng","year":"2022","unstructured":"Zheng W, et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Beh\u00e7et\u2019s disease. Proc Natl Acad Sci USA. 2022;119(26):e2204289119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"810_CR44","doi-asserted-by":"crossref","unstructured":"Lisa G, Clemens S, Michael B. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol. 2019;41.","DOI":"10.1007\/s00281-019-00741-8"},{"key":"810_CR45","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.molimm.2015.07.035","volume":"68","author":"M Galgani","year":"2015","unstructured":"Galgani M, De Rosa V, Matarese G. T cell metabolism and susceptibility to autoimmune diseases. Mol Immunol. 2015;68:558\u201363.","journal-title":"Mol Immunol"},{"key":"810_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/bs.ircmb.2018.05.008","volume":"341","author":"U Khan","year":"2018","unstructured":"Khan U, Ghazanfar H, Lymphocytes T. Autoimmun Int Rev cell Mol biology. 2018;341:125\u201368.","journal-title":"Autoimmun Int Rev cell Mol biology"},{"key":"810_CR47","doi-asserted-by":"publisher","first-page":"102920","DOI":"10.1016\/j.jaut.2022.102920","volume":"133","author":"Y Deng","year":"2022","unstructured":"Deng Y, et al. Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet\u2019s uveitis. J Autoimmun. 2022;133:102920.","journal-title":"J Autoimmun"},{"key":"810_CR48","doi-asserted-by":"crossref","unstructured":"Perez RK, et al. Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science (New York, N.Y.). 2022;376(6589):eabf1970.","DOI":"10.1126\/science.abf1970"},{"key":"810_CR49","doi-asserted-by":"crossref","unstructured":"Mo YQ, et al. Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sj\u00f6gren\u2019s syndrome. J Clin Investig. 2022;132(6).","DOI":"10.1172\/JCI152780"},{"issue":"1","key":"810_CR50","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13073-022-01081-3","volume":"14","author":"M Armaka","year":"2022","unstructured":"Armaka M, et al. Single-cell multimodal analysis identifies common regulatory programs in synovial fibroblasts of rheumatoid arthritis patients and modeled TNF-driven arthritis. Genome Med. 2022;14(1):78.","journal-title":"Genome Med"},{"key":"810_CR51","unstructured":"Mrinal KS. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77."},{"issue":"9","key":"810_CR52","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/s41590-020-0743-0","volume":"21","author":"D Nehar-Belaid","year":"2020","unstructured":"Nehar-Belaid D, et al. Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol. 2020;21(9):1094\u2013106.","journal-title":"Nat Immunol"},{"issue":"2","key":"810_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10875-016-0359-1","volume":"37","author":"GI Rice","year":"2017","unstructured":"Rice GI, et al. Assessment of Type I Interferon Signaling in Pediatric Inflammatory Disease. J Clin Immunol. 2017;37(2):123\u201332.","journal-title":"J Clin Immunol"},{"key":"810_CR54","unstructured":"Nikolaos M, et al. Type I interferon signature in Sj\u00f6gren\u2019s syndrome: pathophysiological and clinical implications. Clin Exp Rheumatol. 2019."},{"key":"810_CR55","doi-asserted-by":"crossref","unstructured":"Brian S, Shervin A. Type I interferon dysregulation in Systemic Sclerosis. Cytokine. 2019;132.","DOI":"10.1016\/j.cyto.2018.12.018"},{"issue":"3","key":"810_CR56","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.xops.2022.100175","volume":"2","author":"J Kuiper","year":"2022","unstructured":"Kuiper J, et al. A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis. Ophthalmol Sci. 2022;2(3):100175.","journal-title":"Ophthalmol Sci"},{"key":"810_CR57","doi-asserted-by":"crossref","unstructured":"Weiwei W, et al. Type I interferon therapy limits CNS autoimmunity by inhibiting CXCR3-mediated trafficking of pathogenic effector T cells. Cell Rep. 2019;28.","DOI":"10.1016\/j.celrep.2019.06.021"},{"issue":"4","key":"810_CR58","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A G\u00fcl","year":"2015","unstructured":"G\u00fcl A. Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37(4):413\u20138.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"810_CR59","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1038\/s41467-024-50472-0","volume":"15","author":"PR Nath","year":"2024","unstructured":"Nath PR, et al. Single-cell profiling identifies a CD8(bright) CD244(bright) Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy. Nat Commun. 2024;15(1):6443.","journal-title":"Nat Commun"},{"key":"810_CR60","doi-asserted-by":"crossref","unstructured":"Wei L, et al. NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis. Sci Rep. 2017;7(1).","DOI":"10.1038\/s41598-017-13412-1"},{"issue":"10","key":"810_CR61","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1084\/jem.20141678","volume":"212","author":"WP Chong","year":"2015","unstructured":"Chong WP, et al. NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-\u03b3-IL-27 axis. J Exp Med. 2015;212(10):1739\u201352.","journal-title":"J Exp Med"},{"issue":"3","key":"810_CR62","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/jcmm.14081","volume":"23","author":"Q Fu","year":"2019","unstructured":"Fu Q, et al. CD83(+) CCR7(+) NK cells induced by interleukin 18 by dendritic cells promote experimental autoimmune uveitis. J Cell Mol Med. 2019;23(3):1827\u201339.","journal-title":"J Cell Mol Med"},{"key":"810_CR63","doi-asserted-by":"crossref","unstructured":"Eric V, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331(6013).","DOI":"10.1126\/science.1198687"},{"issue":"6","key":"810_CR64","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.4049\/jimmunol.153.6.2417","volume":"153","author":"LL Lanier","year":"1994","unstructured":"Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 1994;153(6):2417\u201328.","journal-title":"J Immunol"},{"issue":"12","key":"810_CR65","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.4049\/jimmunol.175.12.7796","volume":"175","author":"DB Rosen","year":"2005","unstructured":"Rosen DB, et al. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol (Baltim Md 1950). 2005;175(12):7796\u20139.","journal-title":"J Immunol (Baltim Md 1950)"},{"issue":"5","key":"810_CR66","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell. 2021;184(5):1281\u2013e129826.","journal-title":"Cell"},{"issue":"2","key":"810_CR67","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4049\/jimmunol.1700387","volume":"200","author":"A Bia\u0142oszewska","year":"2018","unstructured":"Bia\u0142oszewska A, et al. A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes. J Immunol (Baltim Md 1950). 2018;200(2):715\u201324.","journal-title":"J Immunol (Baltim Md 1950)"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00810-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00810-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00810-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:02:29Z","timestamp":1780617749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00810-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00810-7","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In this research study, local researchers were included throughout the research process, including study design, study implementation, data ownership, intellectual property, and authorship of the publication. This study is locally relevant and has been determined in collaboration with local partners. Roles and responsibilities were agreed among collaborators ahead of the research. Written informed consent was obtained from all enrolled patients. The First Affiliated Hospital of Zhengzhou University Medical Ethics Committee (2021-KY-0585-002) and Chongqing Medical University Ethics Committee (No. 2018-048) approved this study. All of the procedures adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Inclusion and ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}